WonKimMD

Oncology • San Francisco, CA

Genitourinary Oncology, Hematologic Oncology

Assistant Clinical Professor of Medicine and Urology

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
2238 Geary Blvd
8th Floor
San Francisco, CA 94115
Phone+1 415-833-3692

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2011 - 2014
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2007 - 2010
Weill Cornell MedicineClass of 2007

Certifications & Licensure

NY State Medical License 2009 - Present
CA State Medical License 2011 - 2025

Clinical Trials

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2014 Sep 02
Terminated
Phase 2

Publications & Presentations

PubMed

86 citations
Erratum: Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer (Cell (2018) 174(3) (758–769.e9), (S0092867418308420) (10.1016/j.cell.2018.06.039))
David A. Quigley, Ha X. Dang, Shuang G. Zhao, Paul Lloyd, Rahul Aggarwal
Cell. 2018-10-18
45 citations
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer
Xiao X. Wei, Andrew C. Hsieh, Won Kim, Terence W. Friedlander, Amy M. Lin
The Oncologist. 2017-05-01
28 citations
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia.
Eric Wang, Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier
Cancer Cell. 2023-01-09